These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8548430)

  • 1. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D; Bara L; Basdevant A; Samama MM
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
    Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO; Abdullah A; Tahzeeb S
    Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of endothelial function are modulated by dietary monounsaturated fat.
    Pérez-Jiménez F; Castro P; López-Miranda J; Paz-Rojas E; Blanco A; López-Segura F; Velasco F; Marín C; Fuentes F; Ordovás JM
    Atherosclerosis; 1999 Aug; 145(2):351-8. PubMed ID: 10488963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increase with age of the components of the tissue factor coagulation pathway is gender-dependent.
    Ariëns RA; Coppola R; Potenza I; Mannucci PM
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):433-7. PubMed ID: 8589210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold value.
    Chadarevian R; Bruckert E; Dejager S; Presberg P; Turpin G
    Thromb Res; 1999 Nov; 96(3):175-82. PubMed ID: 10588459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic and coagulation factors in very old subjects: association with lipoprotein profile and anthropometric variables.
    Vergnani L; Zuliani G; Ricci F; Manzoli N; Carantoni M; Volpato S; Fellin R
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M8-13. PubMed ID: 9467427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
    Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
    Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
    Hansen JB; Grimsgaard S; Huseby N; Sandset PM; Bønaa KH
    Thromb Res; 2001 Apr; 102(1):3-13. PubMed ID: 11323009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.
    Vambergue A; Rugeri L; Gaveriaux V; Devos P; Martin A; Fermon C; Fontaine P; Jude B
    Thromb Res; 2001 Mar; 101(5):367-75. PubMed ID: 11297753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.
    Polac I; Stachowiak G; Jedrzejczyk S; Stetkiewics T; Sobieszczanska S; Pertynski T
    Gynecol Endocrinol; 2003 Apr; 17(2):151-7. PubMed ID: 12744226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
    Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
    Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia.
    Kokawa T; Abumiya T; Kimura T; Harada-Shiba M; Koh H; Tsushima M; Yamamoto A; Kato H
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):504-10. PubMed ID: 7749862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte tissue factor response is decreased in patients with hyperlipidemia.
    Rugeri L; Susen S; Bard JM; Corseaux D; Gavériaux V; Devos P; Lecerf JM; Duriez P; Jude B
    Thromb Res; 1999 Nov; 96(4):283-92. PubMed ID: 10593431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
    Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
    Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.